VWF Deficiency Drives Angiodysplasia via Angiopoietin-2 Dysregulation
New research identifies a molecular pathway linking von Willebrand factor deficiency to gut angiodysplasia, suggesting a targeted therapeutic…
IV Iron Linked to Improved Survival, Anemia Recovery in Acute Infection
A retrospective cohort study suggests intravenous iron administration during acute infection does not worsen outcomes and may offer benefits.
Multiomic Analysis Reveals CTCL Progression Mechanisms, Identifies Therapeutic Targets
A comprehensive multiomic study uncovers specific molecular alterations driving cutaneous T-cell lymphoma progression and therapy resistance.
True Refractoriness to Caplacizumab in iTTP Is Rare
A multicenter study found that delayed platelet recovery in iTTP patients on caplacizumab is usually due to confounding factors, not true…
Itraconazole Inhibits OXPHOS in AML, Targets Therapy-Resistant Leukemic Stem Cells
A drug-repurposing screen identifies the antifungal itraconazole as an oxidative phosphorylation inhibitor effective against AML leukemic stem cells.
Orca-T Immunotherapy Enriches Regulatory-Like T-Cells Early Post-Transplant
A specific T-cell subset, CD4+CD25-FOXP3+Helios+ T conventional cells, is enriched early after Orca-T and correlates with later immune activation.
IL-1β Signaling Drives Aggressive TCF3::HLF B-ALL and Bone Lesions
A new study identifies interleukin-1β as a key driver in a highly aggressive B-cell acute lymphoblastic leukemia subtype.
AL Amyloidosis Prognostic Models Lag Behind Treatment Advances
Current risk stratification tools for AL amyloidosis do not reflect improved patient outcomes with modern daratumumab-based regimens.
TFPI Essential for Embryonic Brain Vessel Development, Protein C Mitigates Defects
A preclinical study in mice reveals tissue factor pathway inhibitor's critical role in preventing cerebrovascular malformations and lethality.
Bispecific CAR T-Cells Show High Response in Extramedullary Multiple Myeloma
A phase 2 trial reports high overall response and manageable safety with anti-BCMA/GPRC5D CAR T-cells for relapsed/refractory disease.
Sickle Cell Trait Not Linked to Overall Mortality or Cardiovascular Disease
A large UK Biobank study finds sickle cell trait does not increase all-cause death or cardiovascular events, but associates with diabetes, kidney…
TP53 and 5q Deletion Drive AML-CK Aneuploidy, Create BCL2 Vulnerability
A new study identifies the genetic drivers of complex karyotype acute myeloid leukemia and a targetable BCL2-dependent vulnerability.